All News

    Camizestrant Combo Improves Progression Time in HR+/HER2– Breast Cancer

    March 1st 2025, 3:00pm

    Article

    Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in HR+/HER2– advanced breast cancer.

    Cema-Cel Has Durable Responses in in Relapsed/Refractory Large B-Cell Lymphoma

    February 28th 2025, 10:00pm

    Article

    Treatment with the CAR T-cell therapy cema-cel demonstrated durable responses in patients with relapsed/refractory large B-cell lymphoma.

    Chemoradiation Benefits for Cervical Cancer May Decline After Age 80

    February 28th 2025, 8:00pm

    Article

    Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study using SEER data.

    A Second Chance I Never Knew I Had After Lymphoma

    February 28th 2025, 6:00pm

    Article

    A year ago, I was told my lymphoma had worsened, but a miraculous turn of events spared me from aggressive chemotherapy, making me grateful for each day of life.

    An Expert Highlights His Key Takeaways From The 2025 ASCO GU Symposium

    February 28th 2025, 5:00pm

    Video

    Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.

    Pregnancy After Glioma Diagnosis Associated With Worse Progression Time

    February 28th 2025, 4:00pm

    Article

    For female patients with glioma, pregnancy after receiving a diagnosis of glioma is associated with worse progression-free survival times.

    There is a Growing Need For Genetic Testing and Precision Medicine in GU Cancers

    February 28th 2025, 2:00pm

    Article

    Dr. Chandler Park helps patients with genitourinary cancers, including both prostate and bladder, understand the importance of genetic testing.

    Fractionated Reirradiation is Safe and Feasible in High-Grade Glioma

    February 27th 2025, 10:00pm

    Article

    Fractionated reirradiation is safe and feasible, suggesting higher reirradiation dose may be feasible in patients with recurrent high-grade glioma.

    ctDNA Alone ‘Not Sufficient’ When Monitoring Patients With Colorectal Cancer

    February 27th 2025, 8:00pm

    Article

    The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients with colorectal cancer.

    My Cousin and I Journey Through Breast, Lung, Pancreatic and Prostate Cancer

    February 27th 2025, 6:00pm

    Article

    After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I committed myself to being there for my cousin.